Track PT Surya Biru Murni Acetylene Tbk's EBIT ($13B) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Sep 30, 2026
Trailing 12 months ending Sep 30, 2026
The latest EBIT for SBMA.JK is $13B as of September 2026. That compares with $20B in the prior-year period — down 35.2% year over year. That is below the sector sector average of $2.4T. Investors often review this figure alongside PT Surya Biru Murni Acetylene Tbk's historical trend and sector peers before judging valuation or financial health.
Over the past year, SBMA.JK's EBIT moved from $20B to $13B — a 35.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in PT Surya Biru Murni Acetylene Tbk's operating scale or balance-sheet position.
Against its sector companies, SBMA.JK currently prints $13B for EBIT, while the sector average sits near $2.4T. That is roughly 99.5% below the sector mean. Large gaps often invite a closer look at PT Surya Biru Murni Acetylene Tbk's growth, margins, and balance sheet.
A EBIT figure of $13B for SBMA.JK is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.4T. Explore the charts below for those layers of context.
After noting SBMA.JK's EBIT ($13B), review year-over-year change from $20B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.